Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
Limited proprietary earnings coverage for EVMN yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 31d ago
Reported figures for Evommune, Inc. — research only, not investment advice.
Updated
What happened recently for Evommune, Inc. (EVMN) — events, not interpretation.
Research & analysis only — not investment advice.
Prior close
$14.65
Market cap
$531.68M
Profitable
No
Revenue $10.00M
Net income
$-12.48M
FY Aug 15, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Evommune, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Evommune, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.